| Process | via Protein(s) | Taxonomy |
|---|
| serotonin receptor signaling pathway | 5-hydroxytryptamine receptor 3E | Homo sapiens (human) |
| monoatomic ion transmembrane transport | 5-hydroxytryptamine receptor 3E | Homo sapiens (human) |
| excitatory postsynaptic potential | 5-hydroxytryptamine receptor 3E | Homo sapiens (human) |
| inorganic cation transmembrane transport | 5-hydroxytryptamine receptor 3E | Homo sapiens (human) |
| regulation of membrane potential | 5-hydroxytryptamine receptor 3E | Homo sapiens (human) |
| chemical synaptic transmission | 5-hydroxytryptamine receptor 3E | Homo sapiens (human) |
| adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway | Metabotropic glutamate receptor 8 | Homo sapiens (human) |
| adenylate cyclase-inhibiting G protein-coupled glutamate receptor signaling pathway | Metabotropic glutamate receptor 8 | Homo sapiens (human) |
| visual perception | Metabotropic glutamate receptor 8 | Homo sapiens (human) |
| G protein-coupled glutamate receptor signaling pathway | Metabotropic glutamate receptor 8 | Homo sapiens (human) |
| regulation of synaptic transmission, glutamatergic | Metabotropic glutamate receptor 8 | Homo sapiens (human) |
| adenylate cyclase-inhibiting G protein-coupled glutamate receptor signaling pathway | Metabotropic glutamate receptor 6 | Homo sapiens (human) |
| G protein-coupled glutamate receptor signaling pathway | Metabotropic glutamate receptor 6 | Homo sapiens (human) |
| chemical synaptic transmission | Metabotropic glutamate receptor 6 | Homo sapiens (human) |
| locomotory behavior | Metabotropic glutamate receptor 6 | Homo sapiens (human) |
| detection of visible light | Metabotropic glutamate receptor 6 | Homo sapiens (human) |
| detection of light stimulus involved in visual perception | Metabotropic glutamate receptor 6 | Homo sapiens (human) |
| retina development in camera-type eye | Metabotropic glutamate receptor 6 | Homo sapiens (human) |
| positive regulation of calcium ion import across plasma membrane | Metabotropic glutamate receptor 6 | Homo sapiens (human) |
| regulation of synaptic transmission, glutamatergic | Metabotropic glutamate receptor 6 | Homo sapiens (human) |
| serotonin receptor signaling pathway | 5-hydroxytryptamine receptor 3B | Homo sapiens (human) |
| monoatomic ion transmembrane transport | 5-hydroxytryptamine receptor 3B | Homo sapiens (human) |
| excitatory postsynaptic potential | 5-hydroxytryptamine receptor 3B | Homo sapiens (human) |
| inorganic cation transmembrane transport | 5-hydroxytryptamine receptor 3B | Homo sapiens (human) |
| chemical synaptic transmission | 5-hydroxytryptamine receptor 3B | Homo sapiens (human) |
| regulation of membrane potential | 5-hydroxytryptamine receptor 3B | Homo sapiens (human) |
| diet induced thermogenesis | Beta-2 adrenergic receptor | Homo sapiens (human) |
| regulation of sodium ion transport | Beta-2 adrenergic receptor | Homo sapiens (human) |
| transcription by RNA polymerase II | Beta-2 adrenergic receptor | Homo sapiens (human) |
| receptor-mediated endocytosis | Beta-2 adrenergic receptor | Homo sapiens (human) |
| smooth muscle contraction | Beta-2 adrenergic receptor | Homo sapiens (human) |
| cell surface receptor signaling pathway | Beta-2 adrenergic receptor | Homo sapiens (human) |
| activation of transmembrane receptor protein tyrosine kinase activity | Beta-2 adrenergic receptor | Homo sapiens (human) |
| adenylate cyclase-modulating G protein-coupled receptor signaling pathway | Beta-2 adrenergic receptor | Homo sapiens (human) |
| endosome to lysosome transport | Beta-2 adrenergic receptor | Homo sapiens (human) |
| response to cold | Beta-2 adrenergic receptor | Homo sapiens (human) |
| positive regulation of protein kinase A signaling | Beta-2 adrenergic receptor | Homo sapiens (human) |
| positive regulation of bone mineralization | Beta-2 adrenergic receptor | Homo sapiens (human) |
| heat generation | Beta-2 adrenergic receptor | Homo sapiens (human) |
| negative regulation of multicellular organism growth | Beta-2 adrenergic receptor | Homo sapiens (human) |
| positive regulation of MAPK cascade | Beta-2 adrenergic receptor | Homo sapiens (human) |
| bone resorption | Beta-2 adrenergic receptor | Homo sapiens (human) |
| negative regulation of G protein-coupled receptor signaling pathway | Beta-2 adrenergic receptor | Homo sapiens (human) |
| positive regulation of transcription by RNA polymerase II | Beta-2 adrenergic receptor | Homo sapiens (human) |
| negative regulation of smooth muscle contraction | Beta-2 adrenergic receptor | Homo sapiens (human) |
| brown fat cell differentiation | Beta-2 adrenergic receptor | Homo sapiens (human) |
| positive regulation of mini excitatory postsynaptic potential | Beta-2 adrenergic receptor | Homo sapiens (human) |
| adrenergic receptor signaling pathway | Beta-2 adrenergic receptor | Homo sapiens (human) |
| adenylate cyclase-activating adrenergic receptor signaling pathway | Beta-2 adrenergic receptor | Homo sapiens (human) |
| positive regulation of protein serine/threonine kinase activity | Beta-2 adrenergic receptor | Homo sapiens (human) |
| positive regulation of cold-induced thermogenesis | Beta-2 adrenergic receptor | Homo sapiens (human) |
| positive regulation of autophagosome maturation | Beta-2 adrenergic receptor | Homo sapiens (human) |
| positive regulation of lipophagy | Beta-2 adrenergic receptor | Homo sapiens (human) |
| cellular response to amyloid-beta | Beta-2 adrenergic receptor | Homo sapiens (human) |
| response to psychosocial stress | Beta-2 adrenergic receptor | Homo sapiens (human) |
| positive regulation of cAMP-dependent protein kinase activity | Beta-2 adrenergic receptor | Homo sapiens (human) |
| positive regulation of AMPA receptor activity | Beta-2 adrenergic receptor | Homo sapiens (human) |
| norepinephrine-epinephrine-mediated vasodilation involved in regulation of systemic arterial blood pressure | Beta-2 adrenergic receptor | Homo sapiens (human) |
| G protein-coupled receptor signaling pathway | Muscarinic acetylcholine receptor M2 | Homo sapiens (human) |
| adenylate cyclase-modulating G protein-coupled receptor signaling pathway | Muscarinic acetylcholine receptor M2 | Homo sapiens (human) |
| phospholipase C-activating G protein-coupled acetylcholine receptor signaling pathway | Muscarinic acetylcholine receptor M2 | Homo sapiens (human) |
| G protein-coupled acetylcholine receptor signaling pathway | Muscarinic acetylcholine receptor M2 | Homo sapiens (human) |
| nervous system development | Muscarinic acetylcholine receptor M2 | Homo sapiens (human) |
| regulation of heart contraction | Muscarinic acetylcholine receptor M2 | Homo sapiens (human) |
| response to virus | Muscarinic acetylcholine receptor M2 | Homo sapiens (human) |
| G protein-coupled serotonin receptor signaling pathway | Muscarinic acetylcholine receptor M2 | Homo sapiens (human) |
| presynaptic modulation of chemical synaptic transmission | Muscarinic acetylcholine receptor M2 | Homo sapiens (human) |
| regulation of smooth muscle contraction | Muscarinic acetylcholine receptor M2 | Homo sapiens (human) |
| adenylate cyclase-inhibiting G protein-coupled acetylcholine receptor signaling pathway | Muscarinic acetylcholine receptor M2 | Homo sapiens (human) |
| G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger | Muscarinic acetylcholine receptor M2 | Homo sapiens (human) |
| chemical synaptic transmission | Muscarinic acetylcholine receptor M2 | Homo sapiens (human) |
| signal transduction | Muscarinic acetylcholine receptor M4 | Homo sapiens (human) |
| cell surface receptor signaling pathway | Muscarinic acetylcholine receptor M4 | Homo sapiens (human) |
| G protein-coupled acetylcholine receptor signaling pathway | Muscarinic acetylcholine receptor M4 | Homo sapiens (human) |
| regulation of locomotion | Muscarinic acetylcholine receptor M4 | Homo sapiens (human) |
| G protein-coupled serotonin receptor signaling pathway | Muscarinic acetylcholine receptor M4 | Homo sapiens (human) |
| adenylate cyclase-inhibiting G protein-coupled acetylcholine receptor signaling pathway | Muscarinic acetylcholine receptor M4 | Homo sapiens (human) |
| G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger | Muscarinic acetylcholine receptor M4 | Homo sapiens (human) |
| chemical synaptic transmission | Muscarinic acetylcholine receptor M4 | Homo sapiens (human) |
| positive regulation of heart rate by epinephrine-norepinephrine | Beta-1 adrenergic receptor | Homo sapiens (human) |
| positive regulation of the force of heart contraction by epinephrine-norepinephrine | Beta-1 adrenergic receptor | Homo sapiens (human) |
| diet induced thermogenesis | Beta-1 adrenergic receptor | Homo sapiens (human) |
| response to cold | Beta-1 adrenergic receptor | Homo sapiens (human) |
| heat generation | Beta-1 adrenergic receptor | Homo sapiens (human) |
| negative regulation of multicellular organism growth | Beta-1 adrenergic receptor | Homo sapiens (human) |
| fear response | Beta-1 adrenergic receptor | Homo sapiens (human) |
| regulation of circadian sleep/wake cycle, sleep | Beta-1 adrenergic receptor | Homo sapiens (human) |
| brown fat cell differentiation | Beta-1 adrenergic receptor | Homo sapiens (human) |
| regulation of postsynaptic membrane potential | Beta-1 adrenergic receptor | Homo sapiens (human) |
| adenylate cyclase-activating adrenergic receptor signaling pathway | Beta-1 adrenergic receptor | Homo sapiens (human) |
| positive regulation of cold-induced thermogenesis | Beta-1 adrenergic receptor | Homo sapiens (human) |
| norepinephrine-epinephrine-mediated vasodilation involved in regulation of systemic arterial blood pressure | Beta-1 adrenergic receptor | Homo sapiens (human) |
| positive regulation of MAPK cascade | Beta-1 adrenergic receptor | Homo sapiens (human) |
| behavioral fear response | 5-hydroxytryptamine receptor 1A | Homo sapiens (human) |
| G protein-coupled receptor signaling pathway | 5-hydroxytryptamine receptor 1A | Homo sapiens (human) |
| adenylate cyclase-inhibiting serotonin receptor signaling pathway | 5-hydroxytryptamine receptor 1A | Homo sapiens (human) |
| serotonin receptor signaling pathway | 5-hydroxytryptamine receptor 1A | Homo sapiens (human) |
| gamma-aminobutyric acid signaling pathway | 5-hydroxytryptamine receptor 1A | Homo sapiens (human) |
| positive regulation of cell population proliferation | 5-hydroxytryptamine receptor 1A | Homo sapiens (human) |
| regulation of serotonin secretion | 5-hydroxytryptamine receptor 1A | Homo sapiens (human) |
| regulation of vasoconstriction | 5-hydroxytryptamine receptor 1A | Homo sapiens (human) |
| exploration behavior | 5-hydroxytryptamine receptor 1A | Homo sapiens (human) |
| regulation of dopamine metabolic process | 5-hydroxytryptamine receptor 1A | Homo sapiens (human) |
| serotonin metabolic process | 5-hydroxytryptamine receptor 1A | Homo sapiens (human) |
| regulation of hormone secretion | 5-hydroxytryptamine receptor 1A | Homo sapiens (human) |
| regulation of behavior | 5-hydroxytryptamine receptor 1A | Homo sapiens (human) |
| chemical synaptic transmission | 5-hydroxytryptamine receptor 1A | Homo sapiens (human) |
| G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger | 5-hydroxytryptamine receptor 1A | Homo sapiens (human) |
| gastric acid secretion | Muscarinic acetylcholine receptor M5 | Homo sapiens (human) |
| G protein-coupled acetylcholine receptor signaling pathway | Muscarinic acetylcholine receptor M5 | Homo sapiens (human) |
| dopamine transport | Muscarinic acetylcholine receptor M5 | Homo sapiens (human) |
| transmission of nerve impulse | Muscarinic acetylcholine receptor M5 | Homo sapiens (human) |
| regulation of phosphatidylinositol dephosphorylation | Muscarinic acetylcholine receptor M5 | Homo sapiens (human) |
| G protein-coupled serotonin receptor signaling pathway | Muscarinic acetylcholine receptor M5 | Homo sapiens (human) |
| G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger | Muscarinic acetylcholine receptor M5 | Homo sapiens (human) |
| chemical synaptic transmission | Muscarinic acetylcholine receptor M5 | Homo sapiens (human) |
| adenylate cyclase-inhibiting G protein-coupled acetylcholine receptor signaling pathway | Muscarinic acetylcholine receptor M5 | Homo sapiens (human) |
| positive regulation of cytokine production | Alpha-2A adrenergic receptor | Homo sapiens (human) |
| DNA replication | Alpha-2A adrenergic receptor | Homo sapiens (human) |
| G protein-coupled receptor signaling pathway | Alpha-2A adrenergic receptor | Homo sapiens (human) |
| adenylate cyclase-activating G protein-coupled receptor signaling pathway | Alpha-2A adrenergic receptor | Homo sapiens (human) |
| adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway | Alpha-2A adrenergic receptor | Homo sapiens (human) |
| Ras protein signal transduction | Alpha-2A adrenergic receptor | Homo sapiens (human) |
| Rho protein signal transduction | Alpha-2A adrenergic receptor | Homo sapiens (human) |
| female pregnancy | Alpha-2A adrenergic receptor | Homo sapiens (human) |
| positive regulation of cell population proliferation | Alpha-2A adrenergic receptor | Homo sapiens (human) |
| negative regulation of norepinephrine secretion | Alpha-2A adrenergic receptor | Homo sapiens (human) |
| regulation of vasoconstriction | Alpha-2A adrenergic receptor | Homo sapiens (human) |
| actin cytoskeleton organization | Alpha-2A adrenergic receptor | Homo sapiens (human) |
| platelet activation | Alpha-2A adrenergic receptor | Homo sapiens (human) |
| positive regulation of cell migration | Alpha-2A adrenergic receptor | Homo sapiens (human) |
| activation of protein kinase activity | Alpha-2A adrenergic receptor | Homo sapiens (human) |
| activation of protein kinase B activity | Alpha-2A adrenergic receptor | Homo sapiens (human) |
| negative regulation of epinephrine secretion | Alpha-2A adrenergic receptor | Homo sapiens (human) |
| cellular response to hormone stimulus | Alpha-2A adrenergic receptor | Homo sapiens (human) |
| receptor transactivation | Alpha-2A adrenergic receptor | Homo sapiens (human) |
| vasodilation | Alpha-2A adrenergic receptor | Homo sapiens (human) |
| glucose homeostasis | Alpha-2A adrenergic receptor | Homo sapiens (human) |
| fear response | Alpha-2A adrenergic receptor | Homo sapiens (human) |
| positive regulation of potassium ion transport | Alpha-2A adrenergic receptor | Homo sapiens (human) |
| positive regulation of MAP kinase activity | Alpha-2A adrenergic receptor | Homo sapiens (human) |
| positive regulation of MAPK cascade | Alpha-2A adrenergic receptor | Homo sapiens (human) |
| positive regulation of epidermal growth factor receptor signaling pathway | Alpha-2A adrenergic receptor | Homo sapiens (human) |
| negative regulation of calcium ion-dependent exocytosis | Alpha-2A adrenergic receptor | Homo sapiens (human) |
| negative regulation of insulin secretion | Alpha-2A adrenergic receptor | Homo sapiens (human) |
| intestinal absorption | Alpha-2A adrenergic receptor | Homo sapiens (human) |
| thermoception | Alpha-2A adrenergic receptor | Homo sapiens (human) |
| negative regulation of lipid catabolic process | Alpha-2A adrenergic receptor | Homo sapiens (human) |
| positive regulation of membrane protein ectodomain proteolysis | Alpha-2A adrenergic receptor | Homo sapiens (human) |
| negative regulation of calcium ion transport | Alpha-2A adrenergic receptor | Homo sapiens (human) |
| negative regulation of insulin secretion involved in cellular response to glucose stimulus | Alpha-2A adrenergic receptor | Homo sapiens (human) |
| negative regulation of uterine smooth muscle contraction | Alpha-2A adrenergic receptor | Homo sapiens (human) |
| adrenergic receptor signaling pathway | Alpha-2A adrenergic receptor | Homo sapiens (human) |
| adenylate cyclase-activating adrenergic receptor signaling pathway | Alpha-2A adrenergic receptor | Homo sapiens (human) |
| adenylate cyclase-inhibiting adrenergic receptor signaling pathway | Alpha-2A adrenergic receptor | Homo sapiens (human) |
| phospholipase C-activating adrenergic receptor signaling pathway | Alpha-2A adrenergic receptor | Homo sapiens (human) |
| positive regulation of wound healing | Alpha-2A adrenergic receptor | Homo sapiens (human) |
| presynaptic modulation of chemical synaptic transmission | Alpha-2A adrenergic receptor | Homo sapiens (human) |
| negative regulation of calcium ion transmembrane transporter activity | Alpha-2A adrenergic receptor | Homo sapiens (human) |
| positive regulation of monoatomic ion transport | Muscarinic acetylcholine receptor M1 | Homo sapiens (human) |
| signal transduction | Muscarinic acetylcholine receptor M1 | Homo sapiens (human) |
| G protein-coupled receptor signaling pathway | Muscarinic acetylcholine receptor M1 | Homo sapiens (human) |
| protein kinase C-activating G protein-coupled receptor signaling pathway | Muscarinic acetylcholine receptor M1 | Homo sapiens (human) |
| phospholipase C-activating G protein-coupled acetylcholine receptor signaling pathway | Muscarinic acetylcholine receptor M1 | Homo sapiens (human) |
| G protein-coupled acetylcholine receptor signaling pathway | Muscarinic acetylcholine receptor M1 | Homo sapiens (human) |
| neuromuscular synaptic transmission | Muscarinic acetylcholine receptor M1 | Homo sapiens (human) |
| nervous system development | Muscarinic acetylcholine receptor M1 | Homo sapiens (human) |
| regulation of locomotion | Muscarinic acetylcholine receptor M1 | Homo sapiens (human) |
| saliva secretion | Muscarinic acetylcholine receptor M1 | Homo sapiens (human) |
| cognition | Muscarinic acetylcholine receptor M1 | Homo sapiens (human) |
| regulation of postsynaptic membrane potential | Muscarinic acetylcholine receptor M1 | Homo sapiens (human) |
| regulation of glial cell proliferation | Muscarinic acetylcholine receptor M1 | Homo sapiens (human) |
| positive regulation of intracellular protein transport | Muscarinic acetylcholine receptor M1 | Homo sapiens (human) |
| G protein-coupled serotonin receptor signaling pathway | Muscarinic acetylcholine receptor M1 | Homo sapiens (human) |
| postsynaptic modulation of chemical synaptic transmission | Muscarinic acetylcholine receptor M1 | Homo sapiens (human) |
| G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger | Muscarinic acetylcholine receptor M1 | Homo sapiens (human) |
| adenylate cyclase-inhibiting G protein-coupled acetylcholine receptor signaling pathway | Muscarinic acetylcholine receptor M1 | Homo sapiens (human) |
| chemical synaptic transmission | Muscarinic acetylcholine receptor M1 | Homo sapiens (human) |
| phospholipase C-activating dopamine receptor signaling pathway | D(2) dopamine receptor | Homo sapiens (human) |
| temperature homeostasis | D(2) dopamine receptor | Homo sapiens (human) |
| response to hypoxia | D(2) dopamine receptor | Homo sapiens (human) |
| negative regulation of protein phosphorylation | D(2) dopamine receptor | Homo sapiens (human) |
| response to amphetamine | D(2) dopamine receptor | Homo sapiens (human) |
| nervous system process involved in regulation of systemic arterial blood pressure | D(2) dopamine receptor | Homo sapiens (human) |
| regulation of heart rate | D(2) dopamine receptor | Homo sapiens (human) |
| regulation of sodium ion transport | D(2) dopamine receptor | Homo sapiens (human) |
| G protein-coupled receptor internalization | D(2) dopamine receptor | Homo sapiens (human) |
| positive regulation of neuroblast proliferation | D(2) dopamine receptor | Homo sapiens (human) |
| positive regulation of receptor internalization | D(2) dopamine receptor | Homo sapiens (human) |
| autophagy | D(2) dopamine receptor | Homo sapiens (human) |
| adenylate cyclase-inhibiting dopamine receptor signaling pathway | D(2) dopamine receptor | Homo sapiens (human) |
| neuron-neuron synaptic transmission | D(2) dopamine receptor | Homo sapiens (human) |
| neuroblast proliferation | D(2) dopamine receptor | Homo sapiens (human) |
| axonogenesis | D(2) dopamine receptor | Homo sapiens (human) |
| synapse assembly | D(2) dopamine receptor | Homo sapiens (human) |
| sensory perception of smell | D(2) dopamine receptor | Homo sapiens (human) |
| long-term memory | D(2) dopamine receptor | Homo sapiens (human) |
| grooming behavior | D(2) dopamine receptor | Homo sapiens (human) |
| locomotory behavior | D(2) dopamine receptor | Homo sapiens (human) |
| adult walking behavior | D(2) dopamine receptor | Homo sapiens (human) |
| protein localization | D(2) dopamine receptor | Homo sapiens (human) |
| negative regulation of cell population proliferation | D(2) dopamine receptor | Homo sapiens (human) |
| associative learning | D(2) dopamine receptor | Homo sapiens (human) |
| visual learning | D(2) dopamine receptor | Homo sapiens (human) |
| response to xenobiotic stimulus | D(2) dopamine receptor | Homo sapiens (human) |
| response to light stimulus | D(2) dopamine receptor | Homo sapiens (human) |
| response to toxic substance | D(2) dopamine receptor | Homo sapiens (human) |
| response to iron ion | D(2) dopamine receptor | Homo sapiens (human) |
| response to inactivity | D(2) dopamine receptor | Homo sapiens (human) |
| Wnt signaling pathway | D(2) dopamine receptor | Homo sapiens (human) |
| striatum development | D(2) dopamine receptor | Homo sapiens (human) |
| orbitofrontal cortex development | D(2) dopamine receptor | Homo sapiens (human) |
| cerebral cortex GABAergic interneuron migration | D(2) dopamine receptor | Homo sapiens (human) |
| adenohypophysis development | D(2) dopamine receptor | Homo sapiens (human) |
| negative regulation of cell migration | D(2) dopamine receptor | Homo sapiens (human) |
| peristalsis | D(2) dopamine receptor | Homo sapiens (human) |
| auditory behavior | D(2) dopamine receptor | Homo sapiens (human) |
| regulation of synaptic transmission, GABAergic | D(2) dopamine receptor | Homo sapiens (human) |
| positive regulation of cytokinesis | D(2) dopamine receptor | Homo sapiens (human) |
| circadian regulation of gene expression | D(2) dopamine receptor | Homo sapiens (human) |
| negative regulation of dopamine secretion | D(2) dopamine receptor | Homo sapiens (human) |
| response to histamine | D(2) dopamine receptor | Homo sapiens (human) |
| response to nicotine | D(2) dopamine receptor | Homo sapiens (human) |
| positive regulation of urine volume | D(2) dopamine receptor | Homo sapiens (human) |
| positive regulation of renal sodium excretion | D(2) dopamine receptor | Homo sapiens (human) |
| positive regulation of multicellular organism growth | D(2) dopamine receptor | Homo sapiens (human) |
| response to cocaine | D(2) dopamine receptor | Homo sapiens (human) |
| negative regulation of circadian sleep/wake cycle, sleep | D(2) dopamine receptor | Homo sapiens (human) |
| dopamine metabolic process | D(2) dopamine receptor | Homo sapiens (human) |
| drinking behavior | D(2) dopamine receptor | Homo sapiens (human) |
| regulation of potassium ion transport | D(2) dopamine receptor | Homo sapiens (human) |
| response to morphine | D(2) dopamine receptor | Homo sapiens (human) |
| pigmentation | D(2) dopamine receptor | Homo sapiens (human) |
| phosphatidylinositol 3-kinase/protein kinase B signal transduction | D(2) dopamine receptor | Homo sapiens (human) |
| positive regulation of G protein-coupled receptor signaling pathway | D(2) dopamine receptor | Homo sapiens (human) |
| negative regulation of blood pressure | D(2) dopamine receptor | Homo sapiens (human) |
| negative regulation of innate immune response | D(2) dopamine receptor | Homo sapiens (human) |
| positive regulation of transcription by RNA polymerase II | D(2) dopamine receptor | Homo sapiens (human) |
| negative regulation of insulin secretion | D(2) dopamine receptor | Homo sapiens (human) |
| acid secretion | D(2) dopamine receptor | Homo sapiens (human) |
| behavioral response to cocaine | D(2) dopamine receptor | Homo sapiens (human) |
| behavioral response to ethanol | D(2) dopamine receptor | Homo sapiens (human) |
| regulation of long-term neuronal synaptic plasticity | D(2) dopamine receptor | Homo sapiens (human) |
| response to axon injury | D(2) dopamine receptor | Homo sapiens (human) |
| branching morphogenesis of a nerve | D(2) dopamine receptor | Homo sapiens (human) |
| arachidonic acid secretion | D(2) dopamine receptor | Homo sapiens (human) |
| epithelial cell proliferation | D(2) dopamine receptor | Homo sapiens (human) |
| negative regulation of epithelial cell proliferation | D(2) dopamine receptor | Homo sapiens (human) |
| negative regulation of protein secretion | D(2) dopamine receptor | Homo sapiens (human) |
| release of sequestered calcium ion into cytosol | D(2) dopamine receptor | Homo sapiens (human) |
| dopamine uptake involved in synaptic transmission | D(2) dopamine receptor | Homo sapiens (human) |
| regulation of dopamine uptake involved in synaptic transmission | D(2) dopamine receptor | Homo sapiens (human) |
| positive regulation of dopamine uptake involved in synaptic transmission | D(2) dopamine receptor | Homo sapiens (human) |
| regulation of synapse structural plasticity | D(2) dopamine receptor | Homo sapiens (human) |
| negative regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction | D(2) dopamine receptor | Homo sapiens (human) |
| negative regulation of synaptic transmission, glutamatergic | D(2) dopamine receptor | Homo sapiens (human) |
| excitatory postsynaptic potential | D(2) dopamine receptor | Homo sapiens (human) |
| positive regulation of growth hormone secretion | D(2) dopamine receptor | Homo sapiens (human) |
| prepulse inhibition | D(2) dopamine receptor | Homo sapiens (human) |
| negative regulation of dopamine receptor signaling pathway | D(2) dopamine receptor | Homo sapiens (human) |
| positive regulation of ERK1 and ERK2 cascade | D(2) dopamine receptor | Homo sapiens (human) |
| regulation of locomotion involved in locomotory behavior | D(2) dopamine receptor | Homo sapiens (human) |
| postsynaptic modulation of chemical synaptic transmission | D(2) dopamine receptor | Homo sapiens (human) |
| presynaptic modulation of chemical synaptic transmission | D(2) dopamine receptor | Homo sapiens (human) |
| negative regulation of cellular response to hypoxia | D(2) dopamine receptor | Homo sapiens (human) |
| positive regulation of glial cell-derived neurotrophic factor production | D(2) dopamine receptor | Homo sapiens (human) |
| positive regulation of long-term synaptic potentiation | D(2) dopamine receptor | Homo sapiens (human) |
| hyaloid vascular plexus regression | D(2) dopamine receptor | Homo sapiens (human) |
| negative regulation of neuron migration | D(2) dopamine receptor | Homo sapiens (human) |
| negative regulation of cytosolic calcium ion concentration | D(2) dopamine receptor | Homo sapiens (human) |
| regulation of dopamine secretion | D(2) dopamine receptor | Homo sapiens (human) |
| negative regulation of adenylate cyclase activity | D(2) dopamine receptor | Homo sapiens (human) |
| phospholipase C-activating dopamine receptor signaling pathway | D(2) dopamine receptor | Homo sapiens (human) |
| negative regulation of voltage-gated calcium channel activity | D(2) dopamine receptor | Homo sapiens (human) |
| positive regulation of MAPK cascade | D(2) dopamine receptor | Homo sapiens (human) |
| adenylate cyclase-activating adrenergic receptor signaling pathway | D(2) dopamine receptor | Homo sapiens (human) |
| MAPK cascade | Alpha-2B adrenergic receptor | Homo sapiens (human) |
| angiogenesis | Alpha-2B adrenergic receptor | Homo sapiens (human) |
| regulation of vascular associated smooth muscle contraction | Alpha-2B adrenergic receptor | Homo sapiens (human) |
| G protein-coupled receptor signaling pathway | Alpha-2B adrenergic receptor | Homo sapiens (human) |
| cell-cell signaling | Alpha-2B adrenergic receptor | Homo sapiens (human) |
| female pregnancy | Alpha-2B adrenergic receptor | Homo sapiens (human) |
| negative regulation of norepinephrine secretion | Alpha-2B adrenergic receptor | Homo sapiens (human) |
| platelet activation | Alpha-2B adrenergic receptor | Homo sapiens (human) |
| activation of protein kinase B activity | Alpha-2B adrenergic receptor | Homo sapiens (human) |
| negative regulation of epinephrine secretion | Alpha-2B adrenergic receptor | Homo sapiens (human) |
| receptor transactivation | Alpha-2B adrenergic receptor | Homo sapiens (human) |
| positive regulation of MAPK cascade | Alpha-2B adrenergic receptor | Homo sapiens (human) |
| positive regulation of neuron differentiation | Alpha-2B adrenergic receptor | Homo sapiens (human) |
| positive regulation of blood pressure | Alpha-2B adrenergic receptor | Homo sapiens (human) |
| positive regulation of uterine smooth muscle contraction | Alpha-2B adrenergic receptor | Homo sapiens (human) |
| adrenergic receptor signaling pathway | Alpha-2B adrenergic receptor | Homo sapiens (human) |
| adenylate cyclase-activating adrenergic receptor signaling pathway | Alpha-2B adrenergic receptor | Homo sapiens (human) |
| regulation of smooth muscle contraction | Alpha-2C adrenergic receptor | Homo sapiens (human) |
| G protein-coupled receptor signaling pathway | Alpha-2C adrenergic receptor | Homo sapiens (human) |
| cell-cell signaling | Alpha-2C adrenergic receptor | Homo sapiens (human) |
| negative regulation of norepinephrine secretion | Alpha-2C adrenergic receptor | Homo sapiens (human) |
| regulation of vasoconstriction | Alpha-2C adrenergic receptor | Homo sapiens (human) |
| platelet activation | Alpha-2C adrenergic receptor | Homo sapiens (human) |
| activation of protein kinase B activity | Alpha-2C adrenergic receptor | Homo sapiens (human) |
| negative regulation of epinephrine secretion | Alpha-2C adrenergic receptor | Homo sapiens (human) |
| receptor transactivation | Alpha-2C adrenergic receptor | Homo sapiens (human) |
| positive regulation of MAPK cascade | Alpha-2C adrenergic receptor | Homo sapiens (human) |
| positive regulation of neuron differentiation | Alpha-2C adrenergic receptor | Homo sapiens (human) |
| adrenergic receptor signaling pathway | Alpha-2C adrenergic receptor | Homo sapiens (human) |
| adenylate cyclase-activating adrenergic receptor signaling pathway | Alpha-2C adrenergic receptor | Homo sapiens (human) |
| negative regulation of insulin secretion | Alpha-2C adrenergic receptor | Homo sapiens (human) |
| calcium-mediated signaling | Muscarinic acetylcholine receptor M3 | Homo sapiens (human) |
| regulation of monoatomic ion transmembrane transporter activity | Muscarinic acetylcholine receptor M3 | Homo sapiens (human) |
| smooth muscle contraction | Muscarinic acetylcholine receptor M3 | Homo sapiens (human) |
| signal transduction | Muscarinic acetylcholine receptor M3 | Homo sapiens (human) |
| G protein-coupled receptor signaling pathway | Muscarinic acetylcholine receptor M3 | Homo sapiens (human) |
| phospholipase C-activating G protein-coupled acetylcholine receptor signaling pathway | Muscarinic acetylcholine receptor M3 | Homo sapiens (human) |
| G protein-coupled acetylcholine receptor signaling pathway | Muscarinic acetylcholine receptor M3 | Homo sapiens (human) |
| synaptic transmission, cholinergic | Muscarinic acetylcholine receptor M3 | Homo sapiens (human) |
| nervous system development | Muscarinic acetylcholine receptor M3 | Homo sapiens (human) |
| positive regulation of insulin secretion | Muscarinic acetylcholine receptor M3 | Homo sapiens (human) |
| protein modification process | Muscarinic acetylcholine receptor M3 | Homo sapiens (human) |
| positive regulation of smooth muscle contraction | Muscarinic acetylcholine receptor M3 | Homo sapiens (human) |
| saliva secretion | Muscarinic acetylcholine receptor M3 | Homo sapiens (human) |
| acetylcholine receptor signaling pathway | Muscarinic acetylcholine receptor M3 | Homo sapiens (human) |
| G protein-coupled serotonin receptor signaling pathway | Muscarinic acetylcholine receptor M3 | Homo sapiens (human) |
| ion channel modulating, G protein-coupled receptor signaling pathway | Muscarinic acetylcholine receptor M3 | Homo sapiens (human) |
| ligand-gated ion channel signaling pathway | Muscarinic acetylcholine receptor M3 | Homo sapiens (human) |
| regulation of smooth muscle contraction | Muscarinic acetylcholine receptor M3 | Homo sapiens (human) |
| G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger | Muscarinic acetylcholine receptor M3 | Homo sapiens (human) |
| adenylate cyclase-inhibiting G protein-coupled acetylcholine receptor signaling pathway | Muscarinic acetylcholine receptor M3 | Homo sapiens (human) |
| chemical synaptic transmission | Muscarinic acetylcholine receptor M3 | Homo sapiens (human) |
| temperature homeostasis | D(1A) dopamine receptor | Homo sapiens (human) |
| conditioned taste aversion | D(1A) dopamine receptor | Homo sapiens (human) |
| behavioral fear response | D(1A) dopamine receptor | Homo sapiens (human) |
| regulation of protein phosphorylation | D(1A) dopamine receptor | Homo sapiens (human) |
| synaptic transmission, dopaminergic | D(1A) dopamine receptor | Homo sapiens (human) |
| response to amphetamine | D(1A) dopamine receptor | Homo sapiens (human) |
| protein import into nucleus | D(1A) dopamine receptor | Homo sapiens (human) |
| G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger | D(1A) dopamine receptor | Homo sapiens (human) |
| adenylate cyclase-activating G protein-coupled receptor signaling pathway | D(1A) dopamine receptor | Homo sapiens (human) |
| activation of adenylate cyclase activity | D(1A) dopamine receptor | Homo sapiens (human) |
| adenylate cyclase-activating dopamine receptor signaling pathway | D(1A) dopamine receptor | Homo sapiens (human) |
| synapse assembly | D(1A) dopamine receptor | Homo sapiens (human) |
| memory | D(1A) dopamine receptor | Homo sapiens (human) |
| mating behavior | D(1A) dopamine receptor | Homo sapiens (human) |
| grooming behavior | D(1A) dopamine receptor | Homo sapiens (human) |
| adult walking behavior | D(1A) dopamine receptor | Homo sapiens (human) |
| visual learning | D(1A) dopamine receptor | Homo sapiens (human) |
| response to xenobiotic stimulus | D(1A) dopamine receptor | Homo sapiens (human) |
| astrocyte development | D(1A) dopamine receptor | Homo sapiens (human) |
| dopamine transport | D(1A) dopamine receptor | Homo sapiens (human) |
| transmission of nerve impulse | D(1A) dopamine receptor | Homo sapiens (human) |
| neuronal action potential | D(1A) dopamine receptor | Homo sapiens (human) |
| dentate gyrus development | D(1A) dopamine receptor | Homo sapiens (human) |
| striatum development | D(1A) dopamine receptor | Homo sapiens (human) |
| cerebral cortex GABAergic interneuron migration | D(1A) dopamine receptor | Homo sapiens (human) |
| positive regulation of cell migration | D(1A) dopamine receptor | Homo sapiens (human) |
| peristalsis | D(1A) dopamine receptor | Homo sapiens (human) |
| operant conditioning | D(1A) dopamine receptor | Homo sapiens (human) |
| synaptic transmission, glutamatergic | D(1A) dopamine receptor | Homo sapiens (human) |
| regulation of dopamine metabolic process | D(1A) dopamine receptor | Homo sapiens (human) |
| vasodilation | D(1A) dopamine receptor | Homo sapiens (human) |
| dopamine metabolic process | D(1A) dopamine receptor | Homo sapiens (human) |
| maternal behavior | D(1A) dopamine receptor | Homo sapiens (human) |
| positive regulation of potassium ion transport | D(1A) dopamine receptor | Homo sapiens (human) |
| glucose import | D(1A) dopamine receptor | Homo sapiens (human) |
| habituation | D(1A) dopamine receptor | Homo sapiens (human) |
| sensitization | D(1A) dopamine receptor | Homo sapiens (human) |
| behavioral response to cocaine | D(1A) dopamine receptor | Homo sapiens (human) |
| positive regulation of release of sequestered calcium ion into cytosol | D(1A) dopamine receptor | Homo sapiens (human) |
| regulation of dopamine uptake involved in synaptic transmission | D(1A) dopamine receptor | Homo sapiens (human) |
| positive regulation of synaptic transmission, glutamatergic | D(1A) dopamine receptor | Homo sapiens (human) |
| prepulse inhibition | D(1A) dopamine receptor | Homo sapiens (human) |
| phospholipase C-activating dopamine receptor signaling pathway | D(1A) dopamine receptor | Homo sapiens (human) |
| long-term synaptic potentiation | D(1A) dopamine receptor | Homo sapiens (human) |
| long-term synaptic depression | D(1A) dopamine receptor | Homo sapiens (human) |
| cellular response to catecholamine stimulus | D(1A) dopamine receptor | Homo sapiens (human) |
| modification of postsynaptic structure | D(1A) dopamine receptor | Homo sapiens (human) |
| presynaptic modulation of chemical synaptic transmission | D(1A) dopamine receptor | Homo sapiens (human) |
| positive regulation of neuron migration | D(1A) dopamine receptor | Homo sapiens (human) |
| positive regulation of MAPK cascade | D(1A) dopamine receptor | Homo sapiens (human) |
| adenylate cyclase-activating adrenergic receptor signaling pathway | D(1A) dopamine receptor | Homo sapiens (human) |
| dopamine receptor signaling pathway | D(1A) dopamine receptor | Homo sapiens (human) |
| positive regulation of MAP kinase activity | D(4) dopamine receptor | Homo sapiens (human) |
| behavioral fear response | D(4) dopamine receptor | Homo sapiens (human) |
| synaptic transmission, dopaminergic | D(4) dopamine receptor | Homo sapiens (human) |
| response to amphetamine | D(4) dopamine receptor | Homo sapiens (human) |
| intracellular calcium ion homeostasis | D(4) dopamine receptor | Homo sapiens (human) |
| adenylate cyclase-inhibiting dopamine receptor signaling pathway | D(4) dopamine receptor | Homo sapiens (human) |
| dopamine receptor signaling pathway | D(4) dopamine receptor | Homo sapiens (human) |
| adult locomotory behavior | D(4) dopamine receptor | Homo sapiens (human) |
| positive regulation of sodium:proton antiporter activity | D(4) dopamine receptor | Homo sapiens (human) |
| positive regulation of kinase activity | D(4) dopamine receptor | Homo sapiens (human) |
| response to histamine | D(4) dopamine receptor | Homo sapiens (human) |
| social behavior | D(4) dopamine receptor | Homo sapiens (human) |
| regulation of dopamine metabolic process | D(4) dopamine receptor | Homo sapiens (human) |
| dopamine metabolic process | D(4) dopamine receptor | Homo sapiens (human) |
| fear response | D(4) dopamine receptor | Homo sapiens (human) |
| regulation of circadian rhythm | D(4) dopamine receptor | Homo sapiens (human) |
| positive regulation of MAP kinase activity | D(4) dopamine receptor | Homo sapiens (human) |
| behavioral response to cocaine | D(4) dopamine receptor | Homo sapiens (human) |
| behavioral response to ethanol | D(4) dopamine receptor | Homo sapiens (human) |
| rhythmic process | D(4) dopamine receptor | Homo sapiens (human) |
| arachidonic acid secretion | D(4) dopamine receptor | Homo sapiens (human) |
| negative regulation of protein secretion | D(4) dopamine receptor | Homo sapiens (human) |
| positive regulation of dopamine uptake involved in synaptic transmission | D(4) dopamine receptor | Homo sapiens (human) |
| inhibitory postsynaptic potential | D(4) dopamine receptor | Homo sapiens (human) |
| regulation of postsynaptic neurotransmitter receptor internalization | D(4) dopamine receptor | Homo sapiens (human) |
| negative regulation of voltage-gated calcium channel activity | D(4) dopamine receptor | Homo sapiens (human) |
| adenylate cyclase-inhibiting serotonin receptor signaling pathway | D(4) dopamine receptor | Homo sapiens (human) |
| G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger | D(4) dopamine receptor | Homo sapiens (human) |
| chemical synaptic transmission | D(4) dopamine receptor | Homo sapiens (human) |
| synaptic transmission, dopaminergic | D(1B) dopamine receptor | Homo sapiens (human) |
| response to amphetamine | D(1B) dopamine receptor | Homo sapiens (human) |
| regulation of systemic arterial blood pressure by vasopressin | D(1B) dopamine receptor | Homo sapiens (human) |
| norepinephrine-epinephrine vasoconstriction involved in regulation of systemic arterial blood pressure | D(1B) dopamine receptor | Homo sapiens (human) |
| intracellular calcium ion homeostasis | D(1B) dopamine receptor | Homo sapiens (human) |
| adenylate cyclase-activating G protein-coupled receptor signaling pathway | D(1B) dopamine receptor | Homo sapiens (human) |
| activation of adenylate cyclase activity | D(1B) dopamine receptor | Homo sapiens (human) |
| adenylate cyclase-activating dopamine receptor signaling pathway | D(1B) dopamine receptor | Homo sapiens (human) |
| chemical synaptic transmission | D(1B) dopamine receptor | Homo sapiens (human) |
| associative learning | D(1B) dopamine receptor | Homo sapiens (human) |
| transmission of nerve impulse | D(1B) dopamine receptor | Homo sapiens (human) |
| negative regulation of NAD(P)H oxidase activity | D(1B) dopamine receptor | Homo sapiens (human) |
| wound healing | D(1B) dopamine receptor | Homo sapiens (human) |
| response to cocaine | D(1B) dopamine receptor | Homo sapiens (human) |
| positive regulation of adenylate cyclase activity | D(1B) dopamine receptor | Homo sapiens (human) |
| negative regulation of blood pressure | D(1B) dopamine receptor | Homo sapiens (human) |
| regulation of female receptivity | D(1B) dopamine receptor | Homo sapiens (human) |
| sensitization | D(1B) dopamine receptor | Homo sapiens (human) |
| phospholipase C-activating dopamine receptor signaling pathway | D(1B) dopamine receptor | Homo sapiens (human) |
| long-term synaptic depression | D(1B) dopamine receptor | Homo sapiens (human) |
| cellular response to catecholamine stimulus | D(1B) dopamine receptor | Homo sapiens (human) |
| reactive oxygen species metabolic process | D(1B) dopamine receptor | Homo sapiens (human) |
| positive regulation of MAPK cascade | D(1B) dopamine receptor | Homo sapiens (human) |
| adenylate cyclase-activating adrenergic receptor signaling pathway | D(1B) dopamine receptor | Homo sapiens (human) |
| dopamine receptor signaling pathway | D(1B) dopamine receptor | Homo sapiens (human) |
| monoamine transport | Sodium-dependent noradrenaline transporter | Homo sapiens (human) |
| neurotransmitter transport | Sodium-dependent noradrenaline transporter | Homo sapiens (human) |
| chemical synaptic transmission | Sodium-dependent noradrenaline transporter | Homo sapiens (human) |
| response to xenobiotic stimulus | Sodium-dependent noradrenaline transporter | Homo sapiens (human) |
| response to pain | Sodium-dependent noradrenaline transporter | Homo sapiens (human) |
| norepinephrine uptake | Sodium-dependent noradrenaline transporter | Homo sapiens (human) |
| neuron cellular homeostasis | Sodium-dependent noradrenaline transporter | Homo sapiens (human) |
| amino acid transport | Sodium-dependent noradrenaline transporter | Homo sapiens (human) |
| norepinephrine transport | Sodium-dependent noradrenaline transporter | Homo sapiens (human) |
| dopamine uptake involved in synaptic transmission | Sodium-dependent noradrenaline transporter | Homo sapiens (human) |
| sodium ion transmembrane transport | Sodium-dependent noradrenaline transporter | Homo sapiens (human) |
| gastric acid secretion | Histamine H2 receptor | Homo sapiens (human) |
| immune response | Histamine H2 receptor | Homo sapiens (human) |
| positive regulation of vasoconstriction | Histamine H2 receptor | Homo sapiens (human) |
| G protein-coupled serotonin receptor signaling pathway | Histamine H2 receptor | Homo sapiens (human) |
| chemical synaptic transmission | Histamine H2 receptor | Homo sapiens (human) |
| G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger | Histamine H2 receptor | Homo sapiens (human) |
| adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway | 5-hydroxytryptamine receptor 1D | Homo sapiens (human) |
| intestine smooth muscle contraction | 5-hydroxytryptamine receptor 1D | Homo sapiens (human) |
| regulation of locomotion | 5-hydroxytryptamine receptor 1D | Homo sapiens (human) |
| vasoconstriction | 5-hydroxytryptamine receptor 1D | Homo sapiens (human) |
| regulation of behavior | 5-hydroxytryptamine receptor 1D | Homo sapiens (human) |
| chemical synaptic transmission | 5-hydroxytryptamine receptor 1D | Homo sapiens (human) |
| G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger | 5-hydroxytryptamine receptor 1D | Homo sapiens (human) |
| adenylate cyclase-inhibiting serotonin receptor signaling pathway | 5-hydroxytryptamine receptor 1D | Homo sapiens (human) |
| G protein-coupled receptor internalization | 5-hydroxytryptamine receptor 1B | Homo sapiens (human) |
| adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway | 5-hydroxytryptamine receptor 1B | Homo sapiens (human) |
| adenylate cyclase-inhibiting serotonin receptor signaling pathway | 5-hydroxytryptamine receptor 1B | Homo sapiens (human) |
| protein kinase C-activating G protein-coupled receptor signaling pathway | 5-hydroxytryptamine receptor 1B | Homo sapiens (human) |
| negative regulation of gamma-aminobutyric acid secretion | 5-hydroxytryptamine receptor 1B | Homo sapiens (human) |
| regulation of dopamine secretion | 5-hydroxytryptamine receptor 1B | Homo sapiens (human) |
| negative regulation of serotonin secretion | 5-hydroxytryptamine receptor 1B | Homo sapiens (human) |
| negative regulation of synaptic transmission, GABAergic | 5-hydroxytryptamine receptor 1B | Homo sapiens (human) |
| response to cocaine | 5-hydroxytryptamine receptor 1B | Homo sapiens (human) |
| vasoconstriction | 5-hydroxytryptamine receptor 1B | Homo sapiens (human) |
| drinking behavior | 5-hydroxytryptamine receptor 1B | Homo sapiens (human) |
| response to ethanol | 5-hydroxytryptamine receptor 1B | Homo sapiens (human) |
| bone remodeling | 5-hydroxytryptamine receptor 1B | Homo sapiens (human) |
| regulation of behavior | 5-hydroxytryptamine receptor 1B | Homo sapiens (human) |
| response to mineralocorticoid | 5-hydroxytryptamine receptor 1B | Homo sapiens (human) |
| negative regulation of synaptic transmission, glutamatergic | 5-hydroxytryptamine receptor 1B | Homo sapiens (human) |
| cellular response to alkaloid | 5-hydroxytryptamine receptor 1B | Homo sapiens (human) |
| cellular response to xenobiotic stimulus | 5-hydroxytryptamine receptor 1B | Homo sapiens (human) |
| cellular response to temperature stimulus | 5-hydroxytryptamine receptor 1B | Homo sapiens (human) |
| presynaptic modulation of chemical synaptic transmission | 5-hydroxytryptamine receptor 1B | Homo sapiens (human) |
| regulation of presynaptic cytosolic calcium ion concentration | 5-hydroxytryptamine receptor 1B | Homo sapiens (human) |
| positive regulation of vascular associated smooth muscle cell proliferation | 5-hydroxytryptamine receptor 1B | Homo sapiens (human) |
| regulation of synaptic vesicle exocytosis | 5-hydroxytryptamine receptor 1B | Homo sapiens (human) |
| chemical synaptic transmission | 5-hydroxytryptamine receptor 1B | Homo sapiens (human) |
| G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger | 5-hydroxytryptamine receptor 1B | Homo sapiens (human) |
| temperature homeostasis | 5-hydroxytryptamine receptor 2A | Homo sapiens (human) |
| positive regulation of cytokine production involved in immune response | 5-hydroxytryptamine receptor 2A | Homo sapiens (human) |
| glycolytic process | 5-hydroxytryptamine receptor 2A | Homo sapiens (human) |
| intracellular calcium ion homeostasis | 5-hydroxytryptamine receptor 2A | Homo sapiens (human) |
| activation of phospholipase C activity | 5-hydroxytryptamine receptor 2A | Homo sapiens (human) |
| positive regulation of cytosolic calcium ion concentration | 5-hydroxytryptamine receptor 2A | Homo sapiens (human) |
| memory | 5-hydroxytryptamine receptor 2A | Homo sapiens (human) |
| positive regulation of cell population proliferation | 5-hydroxytryptamine receptor 2A | Homo sapiens (human) |
| response to xenobiotic stimulus | 5-hydroxytryptamine receptor 2A | Homo sapiens (human) |
| positive regulation of phosphatidylinositol biosynthetic process | 5-hydroxytryptamine receptor 2A | Homo sapiens (human) |
| regulation of dopamine secretion | 5-hydroxytryptamine receptor 2A | Homo sapiens (human) |
| artery smooth muscle contraction | 5-hydroxytryptamine receptor 2A | Homo sapiens (human) |
| urinary bladder smooth muscle contraction | 5-hydroxytryptamine receptor 2A | Homo sapiens (human) |
| positive regulation of heat generation | 5-hydroxytryptamine receptor 2A | Homo sapiens (human) |
| negative regulation of potassium ion transport | 5-hydroxytryptamine receptor 2A | Homo sapiens (human) |
| phosphatidylinositol 3-kinase/protein kinase B signal transduction | 5-hydroxytryptamine receptor 2A | Homo sapiens (human) |
| positive regulation of neuron apoptotic process | 5-hydroxytryptamine receptor 2A | Homo sapiens (human) |
| protein localization to cytoskeleton | 5-hydroxytryptamine receptor 2A | Homo sapiens (human) |
| positive regulation of fat cell differentiation | 5-hydroxytryptamine receptor 2A | Homo sapiens (human) |
| positive regulation of glycolytic process | 5-hydroxytryptamine receptor 2A | Homo sapiens (human) |
| positive regulation of vasoconstriction | 5-hydroxytryptamine receptor 2A | Homo sapiens (human) |
| symbiont entry into host cell | 5-hydroxytryptamine receptor 2A | Homo sapiens (human) |
| sensitization | 5-hydroxytryptamine receptor 2A | Homo sapiens (human) |
| behavioral response to cocaine | 5-hydroxytryptamine receptor 2A | Homo sapiens (human) |
| positive regulation of inflammatory response | 5-hydroxytryptamine receptor 2A | Homo sapiens (human) |
| positive regulation of peptidyl-tyrosine phosphorylation | 5-hydroxytryptamine receptor 2A | Homo sapiens (human) |
| detection of temperature stimulus involved in sensory perception of pain | 5-hydroxytryptamine receptor 2A | Homo sapiens (human) |
| detection of mechanical stimulus involved in sensory perception of pain | 5-hydroxytryptamine receptor 2A | Homo sapiens (human) |
| release of sequestered calcium ion into cytosol | 5-hydroxytryptamine receptor 2A | Homo sapiens (human) |
| negative regulation of synaptic transmission, glutamatergic | 5-hydroxytryptamine receptor 2A | Homo sapiens (human) |
| positive regulation of ERK1 and ERK2 cascade | 5-hydroxytryptamine receptor 2A | Homo sapiens (human) |
| G protein-coupled serotonin receptor signaling pathway | 5-hydroxytryptamine receptor 2A | Homo sapiens (human) |
| presynaptic modulation of chemical synaptic transmission | 5-hydroxytryptamine receptor 2A | Homo sapiens (human) |
| positive regulation of execution phase of apoptosis | 5-hydroxytryptamine receptor 2A | Homo sapiens (human) |
| positive regulation of platelet aggregation | 5-hydroxytryptamine receptor 2A | Homo sapiens (human) |
| positive regulation of DNA biosynthetic process | 5-hydroxytryptamine receptor 2A | Homo sapiens (human) |
| G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger | 5-hydroxytryptamine receptor 2A | Homo sapiens (human) |
| phospholipase C-activating serotonin receptor signaling pathway | 5-hydroxytryptamine receptor 2A | Homo sapiens (human) |
| serotonin receptor signaling pathway | 5-hydroxytryptamine receptor 2A | Homo sapiens (human) |
| chemical synaptic transmission | 5-hydroxytryptamine receptor 2A | Homo sapiens (human) |
| behavioral fear response | 5-hydroxytryptamine receptor 2C | Homo sapiens (human) |
| intracellular calcium ion homeostasis | 5-hydroxytryptamine receptor 2C | Homo sapiens (human) |
| phospholipase C-activating G protein-coupled receptor signaling pathway | 5-hydroxytryptamine receptor 2C | Homo sapiens (human) |
| phospholipase C-activating serotonin receptor signaling pathway | 5-hydroxytryptamine receptor 2C | Homo sapiens (human) |
| locomotory behavior | 5-hydroxytryptamine receptor 2C | Homo sapiens (human) |
| feeding behavior | 5-hydroxytryptamine receptor 2C | Homo sapiens (human) |
| positive regulation of phosphatidylinositol biosynthetic process | 5-hydroxytryptamine receptor 2C | Homo sapiens (human) |
| cGMP-mediated signaling | 5-hydroxytryptamine receptor 2C | Homo sapiens (human) |
| regulation of nervous system process | 5-hydroxytryptamine receptor 2C | Homo sapiens (human) |
| regulation of appetite | 5-hydroxytryptamine receptor 2C | Homo sapiens (human) |
| regulation of corticotropin-releasing hormone secretion | 5-hydroxytryptamine receptor 2C | Homo sapiens (human) |
| positive regulation of fat cell differentiation | 5-hydroxytryptamine receptor 2C | Homo sapiens (human) |
| positive regulation of calcium-mediated signaling | 5-hydroxytryptamine receptor 2C | Homo sapiens (human) |
| release of sequestered calcium ion into cytosol | 5-hydroxytryptamine receptor 2C | Homo sapiens (human) |
| positive regulation of ERK1 and ERK2 cascade | 5-hydroxytryptamine receptor 2C | Homo sapiens (human) |
| G protein-coupled serotonin receptor signaling pathway | 5-hydroxytryptamine receptor 2C | Homo sapiens (human) |
| serotonin receptor signaling pathway | 5-hydroxytryptamine receptor 2C | Homo sapiens (human) |
| G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger | 5-hydroxytryptamine receptor 2C | Homo sapiens (human) |
| chemical synaptic transmission | 5-hydroxytryptamine receptor 2C | Homo sapiens (human) |
| G protein-coupled receptor signaling pathway | 5-hydroxytryptamine receptor 1E | Homo sapiens (human) |
| adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway | 5-hydroxytryptamine receptor 1E | Homo sapiens (human) |
| adenylate cyclase-inhibiting serotonin receptor signaling pathway | 5-hydroxytryptamine receptor 1E | Homo sapiens (human) |
| G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger | 5-hydroxytryptamine receptor 1E | Homo sapiens (human) |
| chemical synaptic transmission | 5-hydroxytryptamine receptor 1E | Homo sapiens (human) |
| monoamine transport | Sodium-dependent serotonin transporter | Homo sapiens (human) |
| response to hypoxia | Sodium-dependent serotonin transporter | Homo sapiens (human) |
| neurotransmitter transport | Sodium-dependent serotonin transporter | Homo sapiens (human) |
| response to nutrient | Sodium-dependent serotonin transporter | Homo sapiens (human) |
| memory | Sodium-dependent serotonin transporter | Homo sapiens (human) |
| circadian rhythm | Sodium-dependent serotonin transporter | Homo sapiens (human) |
| response to xenobiotic stimulus | Sodium-dependent serotonin transporter | Homo sapiens (human) |
| response to toxic substance | Sodium-dependent serotonin transporter | Homo sapiens (human) |
| positive regulation of gene expression | Sodium-dependent serotonin transporter | Homo sapiens (human) |
| positive regulation of serotonin secretion | Sodium-dependent serotonin transporter | Homo sapiens (human) |
| negative regulation of cerebellar granule cell precursor proliferation | Sodium-dependent serotonin transporter | Homo sapiens (human) |
| negative regulation of synaptic transmission, dopaminergic | Sodium-dependent serotonin transporter | Homo sapiens (human) |
| response to estradiol | Sodium-dependent serotonin transporter | Homo sapiens (human) |
| social behavior | Sodium-dependent serotonin transporter | Homo sapiens (human) |
| vasoconstriction | Sodium-dependent serotonin transporter | Homo sapiens (human) |
| sperm ejaculation | Sodium-dependent serotonin transporter | Homo sapiens (human) |
| negative regulation of neuron differentiation | Sodium-dependent serotonin transporter | Homo sapiens (human) |
| positive regulation of cell cycle | Sodium-dependent serotonin transporter | Homo sapiens (human) |
| negative regulation of organ growth | Sodium-dependent serotonin transporter | Homo sapiens (human) |
| behavioral response to cocaine | Sodium-dependent serotonin transporter | Homo sapiens (human) |
| enteric nervous system development | Sodium-dependent serotonin transporter | Homo sapiens (human) |
| brain morphogenesis | Sodium-dependent serotonin transporter | Homo sapiens (human) |
| serotonin uptake | Sodium-dependent serotonin transporter | Homo sapiens (human) |
| membrane depolarization | Sodium-dependent serotonin transporter | Homo sapiens (human) |
| platelet aggregation | Sodium-dependent serotonin transporter | Homo sapiens (human) |
| cellular response to retinoic acid | Sodium-dependent serotonin transporter | Homo sapiens (human) |
| cellular response to cGMP | Sodium-dependent serotonin transporter | Homo sapiens (human) |
| regulation of thalamus size | Sodium-dependent serotonin transporter | Homo sapiens (human) |
| conditioned place preference | Sodium-dependent serotonin transporter | Homo sapiens (human) |
| sodium ion transmembrane transport | Sodium-dependent serotonin transporter | Homo sapiens (human) |
| amino acid transport | Sodium-dependent serotonin transporter | Homo sapiens (human) |
| smooth muscle contraction | 5-hydroxytryptamine receptor 7 | Homo sapiens (human) |
| circadian rhythm | 5-hydroxytryptamine receptor 7 | Homo sapiens (human) |
| blood circulation | 5-hydroxytryptamine receptor 7 | Homo sapiens (human) |
| vasoconstriction | 5-hydroxytryptamine receptor 7 | Homo sapiens (human) |
| G protein-coupled serotonin receptor signaling pathway | 5-hydroxytryptamine receptor 7 | Homo sapiens (human) |
| G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger | 5-hydroxytryptamine receptor 7 | Homo sapiens (human) |
| chemical synaptic transmission | 5-hydroxytryptamine receptor 7 | Homo sapiens (human) |
| MAPK cascade | Alpha-1A adrenergic receptor | Homo sapiens (human) |
| negative regulation of heart rate involved in baroreceptor response to increased systemic arterial blood pressure | Alpha-1A adrenergic receptor | Homo sapiens (human) |
| norepinephrine-epinephrine vasoconstriction involved in regulation of systemic arterial blood pressure | Alpha-1A adrenergic receptor | Homo sapiens (human) |
| positive regulation of heart rate by epinephrine-norepinephrine | Alpha-1A adrenergic receptor | Homo sapiens (human) |
| positive regulation of the force of heart contraction by epinephrine-norepinephrine | Alpha-1A adrenergic receptor | Homo sapiens (human) |
| apoptotic process | Alpha-1A adrenergic receptor | Homo sapiens (human) |
| smooth muscle contraction | Alpha-1A adrenergic receptor | Homo sapiens (human) |
| signal transduction | Alpha-1A adrenergic receptor | Homo sapiens (human) |
| G protein-coupled receptor signaling pathway | Alpha-1A adrenergic receptor | Homo sapiens (human) |
| activation of phospholipase C activity | Alpha-1A adrenergic receptor | Homo sapiens (human) |
| positive regulation of cytosolic calcium ion concentration | Alpha-1A adrenergic receptor | Homo sapiens (human) |
| adult heart development | Alpha-1A adrenergic receptor | Homo sapiens (human) |
| negative regulation of cell population proliferation | Alpha-1A adrenergic receptor | Homo sapiens (human) |
| response to xenobiotic stimulus | Alpha-1A adrenergic receptor | Homo sapiens (human) |
| response to hormone | Alpha-1A adrenergic receptor | Homo sapiens (human) |
| negative regulation of autophagy | Alpha-1A adrenergic receptor | Homo sapiens (human) |
| positive regulation of cardiac muscle hypertrophy | Alpha-1A adrenergic receptor | Homo sapiens (human) |
| positive regulation of synaptic transmission, GABAergic | Alpha-1A adrenergic receptor | Homo sapiens (human) |
| intracellular signal transduction | Alpha-1A adrenergic receptor | Homo sapiens (human) |
| positive regulation of MAPK cascade | Alpha-1A adrenergic receptor | Homo sapiens (human) |
| positive regulation of action potential | Alpha-1A adrenergic receptor | Homo sapiens (human) |
| positive regulation of vasoconstriction | Alpha-1A adrenergic receptor | Homo sapiens (human) |
| positive regulation of smooth muscle contraction | Alpha-1A adrenergic receptor | Homo sapiens (human) |
| calcium ion transport into cytosol | Alpha-1A adrenergic receptor | Homo sapiens (human) |
| positive regulation of cardiac muscle contraction | Alpha-1A adrenergic receptor | Homo sapiens (human) |
| cell growth involved in cardiac muscle cell development | Alpha-1A adrenergic receptor | Homo sapiens (human) |
| positive regulation of ERK1 and ERK2 cascade | Alpha-1A adrenergic receptor | Homo sapiens (human) |
| positive regulation of protein kinase C signaling | Alpha-1A adrenergic receptor | Homo sapiens (human) |
| pilomotor reflex | Alpha-1A adrenergic receptor | Homo sapiens (human) |
| neuron-glial cell signaling | Alpha-1A adrenergic receptor | Homo sapiens (human) |
| phospholipase C-activating G protein-coupled receptor signaling pathway | Alpha-1A adrenergic receptor | Homo sapiens (human) |
| adenylate cyclase-activating adrenergic receptor signaling pathway | Alpha-1A adrenergic receptor | Homo sapiens (human) |
| cell-cell signaling | Alpha-1A adrenergic receptor | Homo sapiens (human) |
| inflammatory response | Histamine H1 receptor | Homo sapiens (human) |
| G protein-coupled receptor signaling pathway | Histamine H1 receptor | Homo sapiens (human) |
| phospholipase C-activating G protein-coupled receptor signaling pathway | Histamine H1 receptor | Homo sapiens (human) |
| memory | Histamine H1 receptor | Homo sapiens (human) |
| visual learning | Histamine H1 receptor | Homo sapiens (human) |
| regulation of vascular permeability | Histamine H1 receptor | Homo sapiens (human) |
| positive regulation of vasoconstriction | Histamine H1 receptor | Homo sapiens (human) |
| regulation of synaptic plasticity | Histamine H1 receptor | Homo sapiens (human) |
| cellular response to histamine | Histamine H1 receptor | Homo sapiens (human) |
| G protein-coupled serotonin receptor signaling pathway | Histamine H1 receptor | Homo sapiens (human) |
| G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger | Histamine H1 receptor | Homo sapiens (human) |
| chemical synaptic transmission | Histamine H1 receptor | Homo sapiens (human) |
| G protein-coupled receptor signaling pathway | Alpha-1B adrenergic receptor | Homo sapiens (human) |
| adenylate cyclase-modulating G protein-coupled receptor signaling pathway | Alpha-1B adrenergic receptor | Homo sapiens (human) |
| regulation of vasoconstriction | Alpha-1B adrenergic receptor | Homo sapiens (human) |
| intracellular signal transduction | Alpha-1B adrenergic receptor | Homo sapiens (human) |
| positive regulation of MAPK cascade | Alpha-1B adrenergic receptor | Homo sapiens (human) |
| regulation of cardiac muscle contraction | Alpha-1B adrenergic receptor | Homo sapiens (human) |
| neuron-glial cell signaling | Alpha-1B adrenergic receptor | Homo sapiens (human) |
| adenylate cyclase-activating adrenergic receptor signaling pathway | Alpha-1B adrenergic receptor | Homo sapiens (human) |
| cell-cell signaling | Alpha-1B adrenergic receptor | Homo sapiens (human) |
| phospholipase C-activating G protein-coupled receptor signaling pathway | Alpha-1B adrenergic receptor | Homo sapiens (human) |
| positive regulation of cytosolic calcium ion concentration | Alpha-1B adrenergic receptor | Homo sapiens (human) |
| G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger | Mu-type opioid receptor | Homo sapiens (human) |
| adenylate cyclase-inhibiting G protein-coupled acetylcholine receptor signaling pathway | Mu-type opioid receptor | Homo sapiens (human) |
| phospholipase C-activating G protein-coupled receptor signaling pathway | Mu-type opioid receptor | Homo sapiens (human) |
| sensory perception | Mu-type opioid receptor | Homo sapiens (human) |
| negative regulation of cell population proliferation | Mu-type opioid receptor | Homo sapiens (human) |
| sensory perception of pain | Mu-type opioid receptor | Homo sapiens (human) |
| G protein-coupled opioid receptor signaling pathway | Mu-type opioid receptor | Homo sapiens (human) |
| behavioral response to ethanol | Mu-type opioid receptor | Homo sapiens (human) |
| positive regulation of neurogenesis | Mu-type opioid receptor | Homo sapiens (human) |
| negative regulation of Wnt protein secretion | Mu-type opioid receptor | Homo sapiens (human) |
| positive regulation of ERK1 and ERK2 cascade | Mu-type opioid receptor | Homo sapiens (human) |
| calcium ion transmembrane transport | Mu-type opioid receptor | Homo sapiens (human) |
| cellular response to morphine | Mu-type opioid receptor | Homo sapiens (human) |
| regulation of cellular response to stress | Mu-type opioid receptor | Homo sapiens (human) |
| regulation of NMDA receptor activity | Mu-type opioid receptor | Homo sapiens (human) |
| neuropeptide signaling pathway | Mu-type opioid receptor | Homo sapiens (human) |
| response to ethanol | D(3) dopamine receptor | Homo sapiens (human) |
| synaptic transmission, dopaminergic | D(3) dopamine receptor | Homo sapiens (human) |
| G protein-coupled receptor internalization | D(3) dopamine receptor | Homo sapiens (human) |
| intracellular calcium ion homeostasis | D(3) dopamine receptor | Homo sapiens (human) |
| G protein-coupled receptor signaling pathway | D(3) dopamine receptor | Homo sapiens (human) |
| adenylate cyclase-activating dopamine receptor signaling pathway | D(3) dopamine receptor | Homo sapiens (human) |
| adenylate cyclase-inhibiting dopamine receptor signaling pathway | D(3) dopamine receptor | Homo sapiens (human) |
| learning or memory | D(3) dopamine receptor | Homo sapiens (human) |
| learning | D(3) dopamine receptor | Homo sapiens (human) |
| locomotory behavior | D(3) dopamine receptor | Homo sapiens (human) |
| visual learning | D(3) dopamine receptor | Homo sapiens (human) |
| response to xenobiotic stimulus | D(3) dopamine receptor | Homo sapiens (human) |
| regulation of dopamine secretion | D(3) dopamine receptor | Homo sapiens (human) |
| positive regulation of cytokinesis | D(3) dopamine receptor | Homo sapiens (human) |
| circadian regulation of gene expression | D(3) dopamine receptor | Homo sapiens (human) |
| response to histamine | D(3) dopamine receptor | Homo sapiens (human) |
| social behavior | D(3) dopamine receptor | Homo sapiens (human) |
| response to cocaine | D(3) dopamine receptor | Homo sapiens (human) |
| dopamine metabolic process | D(3) dopamine receptor | Homo sapiens (human) |
| response to morphine | D(3) dopamine receptor | Homo sapiens (human) |
| negative regulation of blood pressure | D(3) dopamine receptor | Homo sapiens (human) |
| positive regulation of mitotic nuclear division | D(3) dopamine receptor | Homo sapiens (human) |
| acid secretion | D(3) dopamine receptor | Homo sapiens (human) |
| behavioral response to cocaine | D(3) dopamine receptor | Homo sapiens (human) |
| negative regulation of oligodendrocyte differentiation | D(3) dopamine receptor | Homo sapiens (human) |
| arachidonic acid secretion | D(3) dopamine receptor | Homo sapiens (human) |
| negative regulation of protein secretion | D(3) dopamine receptor | Homo sapiens (human) |
| musculoskeletal movement, spinal reflex action | D(3) dopamine receptor | Homo sapiens (human) |
| regulation of dopamine uptake involved in synaptic transmission | D(3) dopamine receptor | Homo sapiens (human) |
| negative regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction | D(3) dopamine receptor | Homo sapiens (human) |
| prepulse inhibition | D(3) dopamine receptor | Homo sapiens (human) |
| positive regulation of dopamine receptor signaling pathway | D(3) dopamine receptor | Homo sapiens (human) |
| negative regulation of adenylate cyclase activity | D(3) dopamine receptor | Homo sapiens (human) |
| adenylate cyclase-activating adrenergic receptor signaling pathway | D(3) dopamine receptor | Homo sapiens (human) |
| negative regulation of voltage-gated calcium channel activity | D(3) dopamine receptor | Homo sapiens (human) |
| regulation of potassium ion transport | D(3) dopamine receptor | Homo sapiens (human) |
| phospholipase C-activating dopamine receptor signaling pathway | D(3) dopamine receptor | Homo sapiens (human) |
| positive regulation of MAPK cascade | D(3) dopamine receptor | Homo sapiens (human) |
| negative regulation of cytosolic calcium ion concentration | D(3) dopamine receptor | Homo sapiens (human) |
| negative regulation of synaptic transmission, glutamatergic | D(3) dopamine receptor | Homo sapiens (human) |
| immune response | Delta-type opioid receptor | Homo sapiens (human) |
| G protein-coupled receptor signaling pathway | Delta-type opioid receptor | Homo sapiens (human) |
| G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger | Delta-type opioid receptor | Homo sapiens (human) |
| adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway | Delta-type opioid receptor | Homo sapiens (human) |
| phospholipase C-activating G protein-coupled receptor signaling pathway | Delta-type opioid receptor | Homo sapiens (human) |
| adult locomotory behavior | Delta-type opioid receptor | Homo sapiens (human) |
| negative regulation of gene expression | Delta-type opioid receptor | Homo sapiens (human) |
| negative regulation of protein-containing complex assembly | Delta-type opioid receptor | Homo sapiens (human) |
| positive regulation of CREB transcription factor activity | Delta-type opioid receptor | Homo sapiens (human) |
| positive regulation of peptidyl-serine phosphorylation | Delta-type opioid receptor | Homo sapiens (human) |
| response to nicotine | Delta-type opioid receptor | Homo sapiens (human) |
| G protein-coupled opioid receptor signaling pathway | Delta-type opioid receptor | Homo sapiens (human) |
| eating behavior | Delta-type opioid receptor | Homo sapiens (human) |
| regulation of mitochondrial membrane potential | Delta-type opioid receptor | Homo sapiens (human) |
| regulation of calcium ion transport | Delta-type opioid receptor | Homo sapiens (human) |
| cellular response to growth factor stimulus | Delta-type opioid receptor | Homo sapiens (human) |
| cellular response to hypoxia | Delta-type opioid receptor | Homo sapiens (human) |
| cellular response to toxic substance | Delta-type opioid receptor | Homo sapiens (human) |
| neuropeptide signaling pathway | Delta-type opioid receptor | Homo sapiens (human) |
| immune response | Kappa-type opioid receptor | Homo sapiens (human) |
| adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway | Kappa-type opioid receptor | Homo sapiens (human) |
| phospholipase C-activating G protein-coupled receptor signaling pathway | Kappa-type opioid receptor | Homo sapiens (human) |
| chemical synaptic transmission | Kappa-type opioid receptor | Homo sapiens (human) |
| sensory perception | Kappa-type opioid receptor | Homo sapiens (human) |
| locomotory behavior | Kappa-type opioid receptor | Homo sapiens (human) |
| sensory perception of pain | Kappa-type opioid receptor | Homo sapiens (human) |
| adenylate cyclase-inhibiting opioid receptor signaling pathway | Kappa-type opioid receptor | Homo sapiens (human) |
| response to insulin | Kappa-type opioid receptor | Homo sapiens (human) |
| positive regulation of dopamine secretion | Kappa-type opioid receptor | Homo sapiens (human) |
| negative regulation of luteinizing hormone secretion | Kappa-type opioid receptor | Homo sapiens (human) |
| response to nicotine | Kappa-type opioid receptor | Homo sapiens (human) |
| G protein-coupled opioid receptor signaling pathway | Kappa-type opioid receptor | Homo sapiens (human) |
| maternal behavior | Kappa-type opioid receptor | Homo sapiens (human) |
| eating behavior | Kappa-type opioid receptor | Homo sapiens (human) |
| response to estrogen | Kappa-type opioid receptor | Homo sapiens (human) |
| estrous cycle | Kappa-type opioid receptor | Homo sapiens (human) |
| response to ethanol | Kappa-type opioid receptor | Homo sapiens (human) |
| regulation of saliva secretion | Kappa-type opioid receptor | Homo sapiens (human) |
| behavioral response to cocaine | Kappa-type opioid receptor | Homo sapiens (human) |
| sensory perception of temperature stimulus | Kappa-type opioid receptor | Homo sapiens (human) |
| defense response to virus | Kappa-type opioid receptor | Homo sapiens (human) |
| cellular response to lipopolysaccharide | Kappa-type opioid receptor | Homo sapiens (human) |
| cellular response to glucose stimulus | Kappa-type opioid receptor | Homo sapiens (human) |
| positive regulation of p38MAPK cascade | Kappa-type opioid receptor | Homo sapiens (human) |
| positive regulation of potassium ion transmembrane transport | Kappa-type opioid receptor | Homo sapiens (human) |
| response to acrylamide | Kappa-type opioid receptor | Homo sapiens (human) |
| positive regulation of eating behavior | Kappa-type opioid receptor | Homo sapiens (human) |
| conditioned place preference | Kappa-type opioid receptor | Homo sapiens (human) |
| neuropeptide signaling pathway | Kappa-type opioid receptor | Homo sapiens (human) |
| neural crest cell migration | 5-hydroxytryptamine receptor 2B | Homo sapiens (human) |
| positive regulation of cytokine production | 5-hydroxytryptamine receptor 2B | Homo sapiens (human) |
| positive regulation of endothelial cell proliferation | 5-hydroxytryptamine receptor 2B | Homo sapiens (human) |
| G protein-coupled receptor internalization | 5-hydroxytryptamine receptor 2B | Homo sapiens (human) |
| heart morphogenesis | 5-hydroxytryptamine receptor 2B | Homo sapiens (human) |
| cardiac muscle hypertrophy | 5-hydroxytryptamine receptor 2B | Homo sapiens (human) |
| intracellular calcium ion homeostasis | 5-hydroxytryptamine receptor 2B | Homo sapiens (human) |
| G protein-coupled receptor signaling pathway | 5-hydroxytryptamine receptor 2B | Homo sapiens (human) |
| activation of phospholipase C activity | 5-hydroxytryptamine receptor 2B | Homo sapiens (human) |
| protein kinase C-activating G protein-coupled receptor signaling pathway | 5-hydroxytryptamine receptor 2B | Homo sapiens (human) |
| phospholipase C-activating serotonin receptor signaling pathway | 5-hydroxytryptamine receptor 2B | Homo sapiens (human) |
| positive regulation of cell population proliferation | 5-hydroxytryptamine receptor 2B | Homo sapiens (human) |
| response to xenobiotic stimulus | 5-hydroxytryptamine receptor 2B | Homo sapiens (human) |
| positive regulation of phosphatidylinositol biosynthetic process | 5-hydroxytryptamine receptor 2B | Homo sapiens (human) |
| neural crest cell differentiation | 5-hydroxytryptamine receptor 2B | Homo sapiens (human) |
| intestine smooth muscle contraction | 5-hydroxytryptamine receptor 2B | Homo sapiens (human) |
| phosphorylation | 5-hydroxytryptamine receptor 2B | Homo sapiens (human) |
| calcium-mediated signaling | 5-hydroxytryptamine receptor 2B | Homo sapiens (human) |
| cGMP-mediated signaling | 5-hydroxytryptamine receptor 2B | Homo sapiens (human) |
| vasoconstriction | 5-hydroxytryptamine receptor 2B | Homo sapiens (human) |
| negative regulation of apoptotic process | 5-hydroxytryptamine receptor 2B | Homo sapiens (human) |
| positive regulation of canonical NF-kappaB signal transduction | 5-hydroxytryptamine receptor 2B | Homo sapiens (human) |
| positive regulation of MAP kinase activity | 5-hydroxytryptamine receptor 2B | Homo sapiens (human) |
| phosphatidylinositol 3-kinase/protein kinase B signal transduction | 5-hydroxytryptamine receptor 2B | Homo sapiens (human) |
| embryonic morphogenesis | 5-hydroxytryptamine receptor 2B | Homo sapiens (human) |
| regulation of behavior | 5-hydroxytryptamine receptor 2B | Homo sapiens (human) |
| positive regulation of nitric-oxide synthase activity | 5-hydroxytryptamine receptor 2B | Homo sapiens (human) |
| release of sequestered calcium ion into cytosol | 5-hydroxytryptamine receptor 2B | Homo sapiens (human) |
| positive regulation of cell division | 5-hydroxytryptamine receptor 2B | Homo sapiens (human) |
| ERK1 and ERK2 cascade | 5-hydroxytryptamine receptor 2B | Homo sapiens (human) |
| positive regulation of ERK1 and ERK2 cascade | 5-hydroxytryptamine receptor 2B | Homo sapiens (human) |
| protein kinase C signaling | 5-hydroxytryptamine receptor 2B | Homo sapiens (human) |
| cellular response to temperature stimulus | 5-hydroxytryptamine receptor 2B | Homo sapiens (human) |
| G protein-coupled serotonin receptor signaling pathway | 5-hydroxytryptamine receptor 2B | Homo sapiens (human) |
| G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger | 5-hydroxytryptamine receptor 2B | Homo sapiens (human) |
| serotonin receptor signaling pathway | 5-hydroxytryptamine receptor 2B | Homo sapiens (human) |
| chemical synaptic transmission | 5-hydroxytryptamine receptor 2B | Homo sapiens (human) |
| serotonin receptor signaling pathway | 5-hydroxytryptamine receptor 3A | Homo sapiens (human) |
| monoatomic ion transmembrane transport | 5-hydroxytryptamine receptor 3A | Homo sapiens (human) |
| excitatory postsynaptic potential | 5-hydroxytryptamine receptor 3A | Homo sapiens (human) |
| inorganic cation transmembrane transport | 5-hydroxytryptamine receptor 3A | Homo sapiens (human) |
| regulation of presynaptic membrane potential | 5-hydroxytryptamine receptor 3A | Homo sapiens (human) |
| chemical synaptic transmission | 5-hydroxytryptamine receptor 3A | Homo sapiens (human) |
| regulation of membrane potential | 5-hydroxytryptamine receptor 3A | Homo sapiens (human) |
| G protein-coupled receptor signaling pathway | 5-hydroxytryptamine receptor 5A | Homo sapiens (human) |
| adenylate cyclase-activating G protein-coupled receptor signaling pathway | 5-hydroxytryptamine receptor 5A | Homo sapiens (human) |
| hippocampus development | 5-hydroxytryptamine receptor 5A | Homo sapiens (human) |
| response to estradiol | 5-hydroxytryptamine receptor 5A | Homo sapiens (human) |
| G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger | 5-hydroxytryptamine receptor 5A | Homo sapiens (human) |
| chemical synaptic transmission | 5-hydroxytryptamine receptor 5A | Homo sapiens (human) |
| adenylate cyclase-inhibiting serotonin receptor signaling pathway | 5-hydroxytryptamine receptor 5A | Homo sapiens (human) |
| cerebral cortex cell migration | 5-hydroxytryptamine receptor 6 | Homo sapiens (human) |
| positive regulation of TOR signaling | 5-hydroxytryptamine receptor 6 | Homo sapiens (human) |
| G protein-coupled serotonin receptor signaling pathway | 5-hydroxytryptamine receptor 6 | Homo sapiens (human) |
| chemical synaptic transmission | 5-hydroxytryptamine receptor 6 | Homo sapiens (human) |
| adenylate cyclase-modulating G protein-coupled receptor signaling pathway | 5-hydroxytryptamine receptor 6 | Homo sapiens (human) |
| G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger | 5-hydroxytryptamine receptor 6 | Homo sapiens (human) |
| monoamine transport | Sodium-dependent dopamine transporter | Homo sapiens (human) |
| neurotransmitter transport | Sodium-dependent dopamine transporter | Homo sapiens (human) |
| lactation | Sodium-dependent dopamine transporter | Homo sapiens (human) |
| sensory perception of smell | Sodium-dependent dopamine transporter | Homo sapiens (human) |
| locomotory behavior | Sodium-dependent dopamine transporter | Homo sapiens (human) |
| response to xenobiotic stimulus | Sodium-dependent dopamine transporter | Homo sapiens (human) |
| response to iron ion | Sodium-dependent dopamine transporter | Homo sapiens (human) |
| dopamine transport | Sodium-dependent dopamine transporter | Homo sapiens (human) |
| adenohypophysis development | Sodium-dependent dopamine transporter | Homo sapiens (human) |
| response to nicotine | Sodium-dependent dopamine transporter | Homo sapiens (human) |
| positive regulation of multicellular organism growth | Sodium-dependent dopamine transporter | Homo sapiens (human) |
| regulation of dopamine metabolic process | Sodium-dependent dopamine transporter | Homo sapiens (human) |
| response to cocaine | Sodium-dependent dopamine transporter | Homo sapiens (human) |
| dopamine biosynthetic process | Sodium-dependent dopamine transporter | Homo sapiens (human) |
| dopamine catabolic process | Sodium-dependent dopamine transporter | Homo sapiens (human) |
| response to ethanol | Sodium-dependent dopamine transporter | Homo sapiens (human) |
| cognition | Sodium-dependent dopamine transporter | Homo sapiens (human) |
| dopamine uptake involved in synaptic transmission | Sodium-dependent dopamine transporter | Homo sapiens (human) |
| response to cAMP | Sodium-dependent dopamine transporter | Homo sapiens (human) |
| norepinephrine uptake | Sodium-dependent dopamine transporter | Homo sapiens (human) |
| prepulse inhibition | Sodium-dependent dopamine transporter | Homo sapiens (human) |
| dopamine uptake | Sodium-dependent dopamine transporter | Homo sapiens (human) |
| hyaloid vascular plexus regression | Sodium-dependent dopamine transporter | Homo sapiens (human) |
| amino acid transport | Sodium-dependent dopamine transporter | Homo sapiens (human) |
| norepinephrine transport | Sodium-dependent dopamine transporter | Homo sapiens (human) |
| sodium ion transmembrane transport | Sodium-dependent dopamine transporter | Homo sapiens (human) |
| G protein-coupled receptor signaling pathway | Metabotropic glutamate receptor 1 | Homo sapiens (human) |
| adenylate cyclase-inhibiting G protein-coupled glutamate receptor signaling pathway | Metabotropic glutamate receptor 1 | Homo sapiens (human) |
| phospholipase C-activating G protein-coupled glutamate receptor signaling pathway | Metabotropic glutamate receptor 1 | Homo sapiens (human) |
| chemical synaptic transmission | Metabotropic glutamate receptor 1 | Homo sapiens (human) |
| locomotory behavior | Metabotropic glutamate receptor 1 | Homo sapiens (human) |
| sensory perception of pain | Metabotropic glutamate receptor 1 | Homo sapiens (human) |
| positive regulation of MAPK cascade | Metabotropic glutamate receptor 1 | Homo sapiens (human) |
| regulation of sensory perception of pain | Metabotropic glutamate receptor 1 | Homo sapiens (human) |
| regulation of postsynaptic membrane potential | Metabotropic glutamate receptor 1 | Homo sapiens (human) |
| cellular response to electrical stimulus | Metabotropic glutamate receptor 1 | Homo sapiens (human) |
| L-glutamate import across plasma membrane | Metabotropic glutamate receptor 1 | Homo sapiens (human) |
| regulation of postsynaptic cytosolic calcium ion concentration | Metabotropic glutamate receptor 1 | Homo sapiens (human) |
| G protein-coupled glutamate receptor signaling pathway | Metabotropic glutamate receptor 1 | Homo sapiens (human) |
| regulation of synaptic transmission, glutamatergic | Metabotropic glutamate receptor 1 | Homo sapiens (human) |
| negative regulation of adenylate cyclase activity | Metabotropic glutamate receptor 2 | Homo sapiens (human) |
| adenylate cyclase-inhibiting G protein-coupled glutamate receptor signaling pathway | Metabotropic glutamate receptor 2 | Homo sapiens (human) |
| chemical synaptic transmission | Metabotropic glutamate receptor 2 | Homo sapiens (human) |
| gene expression | Metabotropic glutamate receptor 2 | Homo sapiens (human) |
| glutamate secretion | Metabotropic glutamate receptor 2 | Homo sapiens (human) |
| regulation of glutamate secretion | Metabotropic glutamate receptor 2 | Homo sapiens (human) |
| regulation of dopamine secretion | Metabotropic glutamate receptor 2 | Homo sapiens (human) |
| behavioral response to nicotine | Metabotropic glutamate receptor 2 | Homo sapiens (human) |
| response to cocaine | Metabotropic glutamate receptor 2 | Homo sapiens (human) |
| positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction | Metabotropic glutamate receptor 2 | Homo sapiens (human) |
| long-term synaptic depression | Metabotropic glutamate receptor 2 | Homo sapiens (human) |
| intracellular glutamate homeostasis | Metabotropic glutamate receptor 2 | Homo sapiens (human) |
| presynaptic modulation of chemical synaptic transmission | Metabotropic glutamate receptor 2 | Homo sapiens (human) |
| regulation of response to drug | Metabotropic glutamate receptor 2 | Homo sapiens (human) |
| G protein-coupled glutamate receptor signaling pathway | Metabotropic glutamate receptor 2 | Homo sapiens (human) |
| regulation of synaptic transmission, glutamatergic | Metabotropic glutamate receptor 2 | Homo sapiens (human) |
| adenylate cyclase-inhibiting G protein-coupled glutamate receptor signaling pathway | Metabotropic glutamate receptor 4 | Homo sapiens (human) |
| chemical synaptic transmission | Metabotropic glutamate receptor 4 | Homo sapiens (human) |
| neurotransmitter secretion | Metabotropic glutamate receptor 4 | Homo sapiens (human) |
| positive regulation of MAPK cascade | Metabotropic glutamate receptor 4 | Homo sapiens (human) |
| regulation of neuron apoptotic process | Metabotropic glutamate receptor 4 | Homo sapiens (human) |
| regulation of synaptic transmission, glutamatergic | Metabotropic glutamate receptor 4 | Homo sapiens (human) |
| G protein-coupled glutamate receptor signaling pathway | Metabotropic glutamate receptor 4 | Homo sapiens (human) |
| serotonin receptor signaling pathway | 5-hydroxytryptamine receptor 3D | Homo sapiens (human) |
| monoatomic ion transmembrane transport | 5-hydroxytryptamine receptor 3D | Homo sapiens (human) |
| excitatory postsynaptic potential | 5-hydroxytryptamine receptor 3D | Homo sapiens (human) |
| inorganic cation transmembrane transport | 5-hydroxytryptamine receptor 3D | Homo sapiens (human) |
| chemical synaptic transmission | 5-hydroxytryptamine receptor 3D | Homo sapiens (human) |
| regulation of membrane potential | 5-hydroxytryptamine receptor 3D | Homo sapiens (human) |
| serotonin receptor signaling pathway | 5-hydroxytryptamine receptor 3C | Homo sapiens (human) |
| monoatomic ion transmembrane transport | 5-hydroxytryptamine receptor 3C | Homo sapiens (human) |
| excitatory postsynaptic potential | 5-hydroxytryptamine receptor 3C | Homo sapiens (human) |
| inorganic cation transmembrane transport | 5-hydroxytryptamine receptor 3C | Homo sapiens (human) |
| regulation of membrane potential | 5-hydroxytryptamine receptor 3C | Homo sapiens (human) |
| chemical synaptic transmission | 5-hydroxytryptamine receptor 3C | Homo sapiens (human) |
| lipid transport | Sigma non-opioid intracellular receptor 1 | Homo sapiens (human) |
| nervous system development | Sigma non-opioid intracellular receptor 1 | Homo sapiens (human) |
| G protein-coupled opioid receptor signaling pathway | Sigma non-opioid intracellular receptor 1 | Homo sapiens (human) |
| regulation of neuron apoptotic process | Sigma non-opioid intracellular receptor 1 | Homo sapiens (human) |
| protein homotrimerization | Sigma non-opioid intracellular receptor 1 | Homo sapiens (human) |
| inflammatory response | Histamine H4 receptor | Homo sapiens (human) |
| positive regulation of cytosolic calcium ion concentration | Histamine H4 receptor | Homo sapiens (human) |
| biological_process | Histamine H4 receptor | Homo sapiens (human) |
| regulation of MAPK cascade | Histamine H4 receptor | Homo sapiens (human) |
| G protein-coupled serotonin receptor signaling pathway | Histamine H4 receptor | Homo sapiens (human) |
| adenylate cyclase-inhibiting G protein-coupled acetylcholine receptor signaling pathway | Histamine H4 receptor | Homo sapiens (human) |
| G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger | Histamine H4 receptor | Homo sapiens (human) |
| chemical synaptic transmission | Histamine H4 receptor | Homo sapiens (human) |
| neurotransmitter secretion | Histamine H3 receptor | Homo sapiens (human) |
| G protein-coupled serotonin receptor signaling pathway | Histamine H3 receptor | Homo sapiens (human) |
| G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger | Histamine H3 receptor | Homo sapiens (human) |
| chemical synaptic transmission | Histamine H3 receptor | Homo sapiens (human) |
| adenylate cyclase-inhibiting G protein-coupled acetylcholine receptor signaling pathway | Histamine H3 receptor | Homo sapiens (human) |
| [Information is prepared from geneontology information from the June-17-2024 release] |